Thymosin-α1 for repeated IVF failure
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a drug called thymosin-α1 can help women who have had two or more failed embryo transfers with genetically normal embryos. It aims to improve the chances of successful implantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You have had at least 2 failed embryo transfers using embryos that were tested and found to be genetically normal.
- You and your partner have normal chromosomes.
- Your uterine cavity looks normal on imaging tests.
- You do not have antiphospholipid antibodies (a type of immune protein that can affect pregnancy).
- Your thyroid and prolactin levels are within normal limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This study compares different acupuncture techniques to see if they can improve the chances of a successful embryo transfer. It is designed for women who have experienced repeated implantation failure, meaning multiple embryos did not implant.
This study tests whether checking the timing of your uterine lining (endometrium) before embryo transfer can help women who have had multiple failed IVF attempts. It may help doctors decide the best day to transfer an embryo to improve the chance of pregnancy.
This study tests whether adding acupuncture to your normal care improves the chance of a successful pregnancy when you have had multiple failed embryo transfers. If you are planning a frozen embryo transferumes, this treatment might increase your odds of success.
This trial studies whether adding acupuncture during embryo transfer and hormone treatment can improve pregnancy outcomes for women who have had repeat IVF implantation failures with no known cause. It may help your chance of clinical pregnancy when you transfer good-quality frozen embryos.
This Phase 3 study tests certolizumab to help people with repeated embryo transfer failures achieve a clinical pregnancy. It may be an option if your infertility has no known cause and you meet the other study checks.
Hear when a new Recurrent Implantation Faliure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.